Compliance Action

The trading platform adds a third regulatory approval, bolstering its compliance framework and setting the stage for strategic expansion in Africa and Asia.

For the 24th straight year, nurses top Gallup's ethics poll, but this enduring trust masks a profession in crisis, battling burnout and staff shortages.

Employer health plans are using 'alternative funding' to cut costs, but critics warn these schemes force patients to use risky, non-FDA approved drugs.

A Tennessee company's patented 1-to-1 CBD and CBDA formula shows promise in fighting inflammation, setting the stage for a new class of FDA-regulated drugs.

The fresh food packaging market is set to soar, but can it balance consumer demands for sustainability, safety, and convenience with the high costs of innovation?

A strategic alliance surpassed its goals sevenfold, fueling small businesses, creating 1,200+ jobs, and offering a new blueprint for rural revitalization.

A new VAB report alleges Nielsen's 'Big Data + Panel' currency is unstable and inaccurate, revealing massive audience variances that threaten media deals.

Quebec food distributor Colabor Group fails to secure a financial lifeline, risking creditor protection and threatening a major regional supply chain disruption.

A data breach at a risk management firm exposes sensitive data for thousands, raising urgent questions about industry security and accountability.

A Maryland community bank is voluntarily leaving Nasdaq. We analyze why shedding public market burdens is an increasingly popular survival strategy.

A Florida health center's new pharmacy is more than a convenience. It's a look into a powerful model blending tech and finance to create sustainable care.

A critical certification for its carbon-storing insulation positions a Maine company to challenge foam and fiberglass dominance in the U.S. building market.

Bigbank's new board appointments signal a strategic pivot, prioritizing robust governance and legal expertise to navigate Europe's complex financial landscape.

A breakthrough stem cell study extends hope for stroke recovery. But a supplement brand is using it to sell 'detox' pills. We separate the facts from fiction.